Skip to main content

Advertisement

Log in

In Vitro and In Vivo Characterization of Transdermal Patch Loaded with Nanostructured Lipid Carrier for Bioavailability Enhancement of Dolutegravir Sodium Using Taguchi and Box-Behnken Design

  • Published:
BioNanoScience Aims and scope Submit manuscript

Abstract

The objective of the present research work was to enhance the bioavailability of dolutegravir sodium (anti-HIV drug) by loading the drug into a nanostructured lipid carrier (NLC), fabricated into the patch, and administered through a transdermal route. For this experimental work, six solid lipids, ten liquid lipids, and nine surfactants were selected for initial screening. The hot high-shear homogenization and melt emulsification low-temperature solidification methods were used to prepare nanostructured lipid carrier formulation. A Taguchi screening method was employed to find out the most influencing factors on critical quality attributes (CQAs) followed by a Box-Behnken design was applied to find the relationship between the independent variables and dependent variables. The selected optimized NLC formulation was characterized, and fabricated into the transdermal patch, and evaluated in a rabbit model for various pharmacokinetic parameters. The optimized formulation was characterized for particle size, zeta potential and polydispersity index (PDI), X-ray diffraction study, transmission electron microscopy analysis, in vitro drug release study, and in vivo pharmacokinetic parameter analysis. The results revealed that the particle size was 151.1 nm, zeta potential − 19.3 mV, and PDI was found to be 0.292. The AUC (0-∞) value of the drug-loaded NLC patch was 8156.426 ng h/ml, whereas 3945.696 ng h/ml and 4751.556 ng h/ml for pure drug and drug-loaded NLC formulation. From the experimental results, it was concluded that the NLC-loaded patch showed better bioavailability, which is nearly twice that of the pure drug administered by oral route. Hence, a fabricated NLC patch will be an assured drug delivery system for ameliorating the bioavailability of dolutegravir.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15

Similar content being viewed by others

Data Availability

All data generated or analyzed during this study are included in this published article.

References

  1. World Health Organization report. https://www.who.int/data/gho/data/themes/hiv-aids. Accessed 23 Dec 2022

  2. Anjum, R., & Lakshmi, P. K. (2020). Dolutegravir sodium loaded solid lipid nanoparticles: A vaginal drug delivery system for pre-exposure prophylaxis of HIV. J Res Pharm., 24(4), 552–561.

    Google Scholar 

  3. Venter, W. D. F., Clayden, P., & Serenata, C. (2017). The ADVANCE study: A groundbreaking trial to evaluate a candidate universal antiretroviral regimen. Current Opinion in HIV and AIDS., 12(4), 351–354. https://doi.org/10.1097/COH.0000000000000389

    Article  Google Scholar 

  4. Shaikh, N. A., & Lala, R. R. (2021). Formulation development of dolutegravir sodium loaded nano lipid carriers for improved solubility and permeability. IJPSR., 12(7), 3654–3665.

    Google Scholar 

  5. Ghasemiyeh, P., & Mohammadi-Samani, S. (2018). Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages. Res Pharm Sci., 13(4), 288–303.

    Article  Google Scholar 

  6. Teng, Z., Yu, M., Ding, Y., Zhang, H., Shen, Y., Jiang, M., Liu, P., Opoku-Damoah, Y., Webster, T. J., & Zhou, J. (2019). Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability. International Journal of Nanomedicine, 14, 119–133.

    Article  Google Scholar 

  7. Brito Raj, S., Chandrasekhar, K. B., & Reddy, K. B. (2019). Formulation, in-vitro and in-vivo pharmacokinetic evaluation of simvastatin nanostructured lipid carrier loaded transdermal drug delivery system. Future Journal of Pharmaceutical Sciences., 5(9), 3–14.

    Google Scholar 

  8. Negi, L. M., Jaggi, M., & Talegaonkar, S. (2014). Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. International Journal of Pharmaceutics, 461, 403–410.

    Article  Google Scholar 

  9. Patel, D., Dasgupta, S., Sanjay Dey, Y., Ramani, R., Ray, S., & Mazumder, B. (2012). Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: Preparation, characterization, and in vivo evaluation. Scientia Pharmaceutica, 80(3), 749–764. https://doi.org/10.3797/scipharm.1202-12

    Article  Google Scholar 

  10. Kosnik, A., Szymanska, E., Czarnomysy, R., Jacyna, J., Markuszewski, M., Basa, A., & Winnicka, K. (2021). Nanostructured lipid carriers engineered as topical delivery of etodolac: Optimization and cytotoxicity studies. Materials., 14, 596. https://doi.org/10.3390/ma14030596

    Article  Google Scholar 

  11. Shailendra, B., Jai Bharti, S., Ruchi, K., Manish, K., Vipin, S., & Shailendra, M. (2021). Design and optimization of febuxostat-loaded nano lipid carriers using full factorial design. Turk J Pharm Sci., 18(1), 61–67.

    Article  Google Scholar 

  12. Cirri, M., Maestrini, L., Maestrelli, F., Mennini, N., Mura, P., Ghelardini, C., Di Cesare, L., & Mannelli,. (2018). Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Drug Delivery, 25(1), 1910–1921.

    Article  Google Scholar 

  13. Iqbal, B., & JavedAli, S. B. (2018). Silymarin loaded nanostructured lipid carrier: From design and dermatokinetic study to mechanistic analysis of epidermal drug deposition enhancement. Journal of Molecular Liquids, 255, 513–529.

    Article  Google Scholar 

  14. Gaba, B., Fazil, M., Khan, S., Ali, A., Baboota, S., & Ali, J. (2015). Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride. Bulletin of Faculty of Pharmacy. Cairo University., 53, 147–159.

    Google Scholar 

  15. Bahari, L. A. S., & Hamishehkar, H. (2016). The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; A comparative literature Review. Adv Pharm Bull., 6(2), 143–151.

    Article  Google Scholar 

  16. Sharma, A., & Baldi, A. (2018). Nanostructured lipid carriers: A review. J Develop Drugs., 7(1), 1–12. https://doi.org/10.4172/2329-6631.1000191

    Article  Google Scholar 

  17. Hanifiyah, I. A., Rosita, N., & Purwanti, T. (2021). Production method of nanostructured lipid carrier (NLC): Hot and cold homogenization against NLC-coenzyme Q10 characteristics. Journal of Computational and Theoretical Nanoscience., 18(1), 26–31. https://doi.org/10.1166/jctn.2021.9467

    Article  Google Scholar 

  18. Singh, A. P., Sharma, S. K., Gaur, P. K., & Gupta, D. K. (2021). Fabrication of mupirocin-loaded nanostructured lipid carrier and its in vitro characterization. ASSAY and drug development technologies, 19(4), 216–225. https://doi.org/10.1089/adt.2020.1070

    Article  Google Scholar 

  19. Jain, K., Sood, S., & Gowthamarajan, K. (2015). Optimization of artemether loaded NLC for intranasal delivery using central composite design. Drug Delivery, 22, 940–954.

    Article  Google Scholar 

  20. Uprit, S., Sahu, R. K., Roy, A., & Pare, A. (2013). Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm J., 21(4), 379–385. https://doi.org/10.1016/j.jsps.2012.11.005

    Article  Google Scholar 

  21. Shah, N. V., Seth, A. K., Balaraman, R., Aundhia, C. J., Maheshwari, R. A., & Parma, G. R. (2016). Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study. Journal of Advanced Research., 7, 423–434. https://doi.org/10.1016/j.jare.2016.03.002

    Article  Google Scholar 

  22. Cirri, M., Bragagni, M., Mennini, N., & Mura, P. (2012). Development of a new delivery system consisting in ‘“drug–in cyclodextrin– in nanostructured lipid carriers”’ for ketoprofen topical delivery. European Journal of Pharmaceutics and Biopharmaceutics., 80, 46–53.

    Article  Google Scholar 

  23. People PV, & Singh, K. K. (2011). Development and evaluation of colloidal modified nano lipid carrier: Application to topical delivery of tacrolimus. Eur J Pharm Biopharm., 79, 82–94.

    Article  Google Scholar 

  24. Tran, T. H., Ramasamy, T., Truong, D. H., Choi, H.-G., Yong, C. S., & Kim, J. O. (2014). Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement. AAPS Pharm SciTech., 15(6), 1509–1515. https://doi.org/10.1208/s12249-014-0175-y

    Article  Google Scholar 

  25. Izham, M. N. M., Hussin, Y., Rahim, N. F. C., Aziz, M. N. M., Yeap, S. K., Rahman, H. S., Masarudin, M. J., Mohamad, N. E., Abdullah, R., & Alitheen, N. B. (2021). Physicochemical characterization, cytotoxic effect and toxicity evaluation of nanostructured lipid carrier loaded with eucalyptol. BMC Complement Med Ther., 21(254), 1–17. https://doi.org/10.1186/s12906-021-03422-y

    Article  Google Scholar 

  26. Ortiz, A. C., Yanez, O., Salas-Huenuleo, E., & Morales, J. O. (2021). Development of a nanostructured lipid carrier (NLC) by a low-energy method, comparison of release kinetics and molecular dynamics simulation. Pharmaceutics., 13(4), 531. https://doi.org/10.3390/pharmaceutics13040531

    Article  Google Scholar 

  27. Samiullah, UmerJan, Syed, Gul, Rahman, Jalaludin, Syed, & Asmathullah. (2020). Formulation and evaluation of transdermal patches of pseudoephedrine hcl. Int J App Pharm, 12(3), 121–127. https://doi.org/10.22159/ijap.2020v12i3.37080

    Article  Google Scholar 

  28. Suryani, W. O. S. M., Ruslin, M. N., Rima, A., Marganita, H., et al. (2019). Formulation and physical characterization of curcumin nanoparticle transdermal patch. Int J Appl Pharm., 11, 217–221.

    Article  Google Scholar 

  29. Pankaj Sharma and Mukul Tailang. (2022). Primaquine-loaded transdermal patch for treating malaria: Design, development, and characterization. Future Journal of Pharmaceutical Sciences., 8, 43. https://doi.org/10.1186/s43094-022-00433-5

    Article  Google Scholar 

  30. Bazigha, K., Rasool, A., Mohammed, A. A., & Salem, Y. Y. (2021). The optimization of a dimenhydrinate transdermal patch formulation based on the quantitative analysis of in vitro release data by DDsolver through skin penetration studies. Scientia Pharmaceutica, 89(3), 33. https://doi.org/10.3390/scipharm89030033

    Article  Google Scholar 

  31. Arunprasert, K., Pornpitchanarong, C., Piemvuthi, C., Siraprapapornsakul, S., Sripeangchan, S., Lertsrimongkol, O., Opanasopit, P., & Patrojanasophon, P. (2022). Nanostructured lipid carrier-embedded polyacrylic acid transdermal patches for improved transdermal delivery of capsaicin. European Journal of Pharmaceutical Sciences, 173, 106169. https://doi.org/10.1016/j.ejps.2022.106169

    Article  Google Scholar 

  32. Chauhan, I., Yasi, M., Verma, M., & Singh, A. P. (2020). Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery. Adv Pharm Bull, 10(2), 150–165. https://doi.org/10.34172/apb.2020.021

    Article  Google Scholar 

Download references

Acknowledgements

The authors wish to acknowledge the Roland Institute of Pharmaceutical Sciences for providing facilities to carry out the research work.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study’s conception and design. Material preparation, data collection, and analysis were performed by all authors. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Laxmidhar Sahoo.

Ethics declarations

Ethics Approval

The conducted research work was approved by the IAEC (institutional animal ethical committee) with Reg. number 926/PO/Re/s/06 and approval no. 143.

Consent to Participate

The research study does not involve human subject.

Consent for Publication

This study does not contain any individual person’s data at any form.

Competing Interests

The authors declare no competing interests.

Animal Studies

All institutional and national guidelines for the care and use of laboratory animals were followed.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sahoo, L., Jena, G.K., Patro, C.S. et al. In Vitro and In Vivo Characterization of Transdermal Patch Loaded with Nanostructured Lipid Carrier for Bioavailability Enhancement of Dolutegravir Sodium Using Taguchi and Box-Behnken Design. BioNanoSci. 13, 1213–1230 (2023). https://doi.org/10.1007/s12668-023-01143-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12668-023-01143-9

Keywords

Navigation